Literature DB >> 14606090

Changes of CD8+CD28- T regulatory cells in rat model of colitis induced by 2,4-dinitrofluorobenzene.

Wen-Bin Xiao1, Yu-Lan Liu.   

Abstract

AIM: To determine the changes of CD8+ T subsets especially CD8+CD28- T regulatory cells in rat model of experimental colitis induced by 2,4-dinitrofluorobenzene (DNFB).
METHODS: The rat model of experimental colitis was induced by enema with DNFB. Ten days later, colonic intraepithelial and splenic lymphocytes were isolated from colitis animals (n=16) and controls (n=8). The proportion of CD8+ T cells, CD8+CD28+ T cells and CD8+CD28- T regulatory cells were determined by flow cytometry.
RESULTS: The model of experimental colitis was successfully established by DNFB that was demonstrated by bloody diarrhea, weight loss and colonic histopathology. The proportion of CD8+ T cells in either splenic or colonic intraepithelial lymphocytes was not significantly different between colitis animals and controls (spleen: 34.6+/-7.24% vs 33.5+/-9.41%, colon: 14.0+/-8.93% vs 18.0+/-4.06%, P>0.05). But CD8+CD28- T regulatory cells from colitis animals were significantly more than those from controls (spleen: 11.3+/-2.26% vs 5.64+/-1.01%, colon: 6.50+/-5.37% vs 1.07+/-0.65%, P<0.05). In contrast, CD8+CD28+ T cells from colitis animals were less than those from controls (spleen: 23.3+/-6.14% vs 27.8+/-9.70%, P=0.06; colon: 7.52+/-4.18% vs 16.9+/-4.07%, P<0.05). The proportion of CD8+CD28- T regulatory cells in splenic and colon intraepithelial CD8+ T cells from colitis animals was higher than that from controls (spleen: 33.3+/-5.49% vs 18.4+/-7.26%, colon: 46.0+/-14.3% vs 6.10+/-3.72%, P<0.005).
CONCLUSION: Experimental colitis of rats can be induced by DNFB with simplicity and good reproducibility. The proportion of CD8+CD28- T regulatory cells in rats with experimental colitis is increased, which may be associated with the pathogenesis of colitis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14606090      PMCID: PMC4656534          DOI: 10.3748/wjg.v9.i11.2528

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

Review 1.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

Review 2.  The immunology of inflammatory bowel disease.

Authors:  Scott Plevy
Journal:  Gastroenterol Clin North Am       Date:  2002-03       Impact factor: 3.806

3.  Phenotypic characterization of isolated intraepithelial lymphocytes in patients with ulcerative colitis and normal controls.

Authors:  P Hoang; M Senju; J R Lowes; D P Jewell
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

4.  Lymphocyte subpopulations, lymphoblast transformation activity, and concanavalin A-induced suppressor activity in patients with ulcerative colitis and Crohn's disease.

Authors:  B Davidsen; E Kristensen
Journal:  Scand J Gastroenterol       Date:  1987-09       Impact factor: 2.423

5.  Animal models of inflammatory bowel disease.

Authors:  M Banić; B Anić; T Brkić
Journal:  Acta Med Croatica       Date:  1997

6.  Effect of methylprednisolone on small bowel, spleen and liver changes in a murine model of inflammatory bowel disease.

Authors:  M Banić; T Brkić; B Anić; I Rotkvić; Z Grabarević; M Duvnjak; B Troskot; S Mihatov
Journal:  Aliment Pharmacol Ther       Date:  1993-04       Impact factor: 8.171

7.  T lymphocyte subsets in inflammatory bowel disease: peripheral blood.

Authors:  W S Selby; D P Jewell
Journal:  Gut       Date:  1983-02       Impact factor: 23.059

8.  Comparison of parenteral nutrition and enteral feeding with pectin in experimental colitis in the rat.

Authors:  R H Rolandelli; S H Saul; R G Settle; D O Jacobs; S O Trerotola; J L Rombeau
Journal:  Am J Clin Nutr       Date:  1988-04       Impact factor: 7.045

9.  Suppressor T cell circuits in contact sensitivity. II. Induction and characterization of an efferent-acting, antigen-specific, H-2-restricted, monoclonal T cell hybrid-derived suppressor factor specific for DNFB contact hypersensitivity.

Authors:  S D Miller
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

10.  Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation.

Authors:  S Read; V Malmström; F Powrie
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

View more
  4 in total

1.  Disequilibrium in the CD8+CD28+/CD8+CD28- T Lymphocyte Balance Is Related to Prognosis in Rats with Trinitrobenzenesulfonic Acid-Induced Colitis.

Authors:  Shixue Dai; Hongxiang Gu; Qianyi Lin; Tiaosi Xing; Minhua Chen; Tao Zhong; Gang Wu; Yanling Feng; Hongbo Liu; Yong Gao; Hongjian Jian; Minhai Zhang; Hongmei Mo; Huanjie Zhu; Dongsheng Chen; Jun Xu; Ying Zou; Honggang Chi; Yuzhen Zhu
Journal:  Dig Dis Sci       Date:  2016-12-29       Impact factor: 3.199

2.  Effect of azithromycin on acute inflammatory lesions and colonic bacterial load in a murine model of experimental colitis.

Authors:  Sanja Plesko; Marko Banić; Vanda Plecko; Branimir Anić; Tomislav Brkić; Heinzl Renata; Ivo Rotkvić
Journal:  Dig Dis Sci       Date:  2009-11-19       Impact factor: 3.199

3.  Streptococcus pneumoniae serotype 1 capsular polysaccharide induces CD8CD28 regulatory T lymphocytes by TCR crosslinking.

Authors:  Janina Mertens; Mario Fabri; Alessandra Zingarelli; Torsten Kubacki; Sonja Meemboor; Laura Groneck; Jens Seeger; Martina Bessler; Helena Hafke; Margarete Odenthal; Joan G Bieler; Christoph Kalka; Jonathan P Schneck; Hamid Kashkar; Wiltrud M Kalka-Moll
Journal:  PLoS Pathog       Date:  2009-09-25       Impact factor: 6.823

4.  Strain differences in thymic atrophy in rats immunized for EAE correlate with the clinical outcome of immunization.

Authors:  Mirjana Nacka-Aleksić; Marija Stojanović; Ivan Pilipović; Zorica Stojić-Vukanić; Duško Kosec; Gordana Leposavić
Journal:  PLoS One       Date:  2018-08-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.